Key result
Pan-Immune-Inflammatory Value fails to predict hospital stay duration in myocarditis but tracks IV steroid use.
Why the study?
The predictive value of the Pan-Immune-Inflammatory Value (PIV) index for hospital stay duration in myocarditis patients was unclear.
Does the Pan-Immune-Inflammatory Value (PIV) index predict the duration of hospital stay in patients with myocarditis?
Observational
Does the Pan-Immune-Inflammatory Value (PIV) index predict the duration of hospital stay in patients with myocarditis?
While the PIV index does not independently predict hospital stay duration in myocarditis, it correlates with disease severity markers like pericardial effusion and the need for intravenous steroids.
PIV may predict myocarditis hospitalization length; hypothesis-generating and requires prospective validation before any clinical use.
Background: Myocarditis is an inflammatory disease of the myocardium that can result from various etiologies, most commonly viral or bacterial infections and autoimmune processes. This study aimed to evaluate the predictive value of the Pan-Immune-Inflammatory Value (PIV) index for the duration of hospitalization. Methods: Laboratory parameters, comorbidities, and treatment data of patients diagnosed with myocarditis were retrospectively analyzed. Patients were divided into two groups: those discharged within 48 hours and those hospitalized for more than 48 hours. The relationship between the PIV index and the duration of hospital stay was evaluated. Results: Patients with a hospital stay longer than 2 days were significantly younger (p < 0.001). Red cell distribution width, C-reactive protein, and troponin levels were significantly higher in patients with prolonged hospitalization (p < 0.001, p < 0.001, p = 0.013, respectively). PIV values were significantly higher in patients with pericardial effusion and in those receiving intravenous steroid therapy (p < 0.001). Conclusions: Although PIV alone was not a statistically significant predictor of hospital stay duration, it was associated with markers of systemic inflammation and disease severity. PIV may serve as a supportive biomarker in the clinical assessment of myocarditis patients.
No takes yet. Share an insight, caveat, or question.
Eyiol et al. (2026) conducted an observational in Myocarditis. Pan-Immune-Inflammatory Value (PIV) index was evaluated on Duration of hospitalization (discharged within 48 hours vs hospitalized for more than 48 hours). The Pan-Immune-Inflammatory Value index was not a significant predictor of hospital stay duration in myocarditis, but was significantly higher in patients receiving intravenous steroids (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: